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Abstract
Background:  Experimental autoimmune encephalomyelitis (EAE) is commonly used to investigate
mechanisms of autoimmune-mediated damage to oligodendrocytes, myelin, and axons in multiple sclerosis
(MS). Four distinct autoimmune mechanisms with subsequently distinct patterns of demyelination have
been recognized in acute MS lesions. EAE correlates for those distinct patterns of MS lesions are unknown.
An excessive loss of myelin-associated glycoprotein (MAG), as a result of distal oligodendrogliopathy, is
found exclusively in the subtype III lesion. We sought to answer if types of demyelination in acute lesions
during onset and relapse of EAE can replicate the specific patterns observed in MS acute lesions.
Methods: In parental H-2b (C57BL/6, B6) and hybrid H-2b/s [(B6 × SJL) F1] EAE mice, we examined spinal
cord levels of MOG, MAG, and myelin basic protein (MBP), and compared to levels of axonal
neurofilament (NF160) to assess axonal function, and levels of PARPp85 as an indicator of irreversible
apoptosis.
Results:  During disease onset, levels of MOG significantly dropped in both strains, although more
profoundly in H-2b/s mice. Levels of MOG recovered in relapsing mice of both strains. Regulation of MAG
w a s  d i s s i m i l a r  t o  M O G .  M o d e s t  l o s s  o f  M A G  w a s  found at disease onset in both strains of mice.
Unexpectedly, in relapsing H-2b/s mice, a major depletion of MAG and NF160, accompanied with sharp
elevation of PARPp85 levels, was measured. PARPp85 immunoreactivity was observed in cytoplasm and
nuclei of some MBP containing cells.
Conclusion: Taken together, our results show genetically controlled distinct patterns of MOG and MAG
depletion, in MOG35–55 induced EAE in H-2b and H-2b/s mice. The data also suggest distinctive immune
regulation of acute lesions that develop in relapsing compared to disease onset. A profound depletion of
MAG, concomitant with marked depletion of axonal NF160, and sharp elevation of PARPp85 levels,
occurred exclusively in relapsing H-2b/s mice. Our findings suggest concurrence of sharp decrease of MAG
levels, axonal dysfunction and irreversible apoptosis with severe relapsing disease in H-2b/s mice. We
propose that MOG-induced EAE in H-2b/s mice may prove as a useful model in studying mechanisms, which
govern autoimmune-induced preferential loss of MAG, and its impact on oligodendroglial pathology.
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Background
Multiple sclerosis (MS) is debilitating neurological disor-
der with unknown etiology. Genetic control of suscepti-
bility to MS has been linked to different DR and DQ loci
within MHC class II. In patients with MS, autoimmune
mediated inflammation, demyelination and axonal dam-
age are commonly found within CNS lesions.
Experimental autoimmune encephalomyelitis (EAE) is an
animal model, extensively used to gain better understand-
ing into mechanisms of autoimmune mediated inflam-
mation, demyelination and axonal damage. In mice,
susceptibility to EAE is determined by H-2 restricted
autoimmune responses to immunodominant epitopes of
myelin proteins. This genetic control of autoimmune-
induced encephalitogenic responses impact clinical symp-
toms, immunopathology and histopathology of EAE, and
its similarities with the clinical course and histopathology
of MS. Subsequently four distinct patterns, suggestive of
different, specific underlying immune regulatory mecha-
nisms have been proposed in MS [1]. Prominent changes
typically observed in type III demyelination include signs
of distal oligodendrogliopathy. An initial indicator of oli-
godendrocyte specific damage is depletion of myelin asso-
ciated glycoprotein (MAG), which is a type I
transmembrane glycoprotein positioned at periaxonal
regions in the inner most loop of the oligodendrocyte cell
processes. Specific loss of MAG is suggestive of oligoden-
droglial dysfunction and/or their death by apoptosis [2].
Because of the indispensable role of oligodendrocytes in
myelin and axonal homeostasis, mechanisms of oli-
godendrocyte apoptosis remain among focal points in
understanding immunopathogenesis of MS [3]. In both
human disease and EAE, presence of apoptotic oli-
godendrocytes, but also infiltrating mononuclear cells,
which undergo activation-induced cell death, has been
documented. Subsequently, changes in levels of several
pro- and anti-apoptotic regulatory molecules, including
activation of terminal caspases, have been observed in MS
and some models of EAE [4]. In this study we measured
levels of PARPp85, which is an 85 kD caspase cleaved frag-
ment of a DNA binding enzyme, poly (ADP-ribose)
polymerase (PARP), and whose presence indicates irre-
versible apoptosis. In its cleaved form, PARP is insufficient
in supporting DNA repair by itself and by other DNA
binding enzymes.
Inflammatory demyelination initiates axonal dysfunction
and/or loss, especially in relapsing-remitting MS. Damage
and subsequent loss of axonal cytoskeletal neurofila-
ments correlates directly with neurological disability in
MS [5]. The medium chain of neurofilament (NF160) is
essential for myelination-dependent outside-in signaling,
which arises from oligodendrocytes and controls axonal
caliber and conduction velocity of motor axons [6,7].
As opposed to the extensively studied histopathology of
heterogeneous lesions in human disease, it is largely
unknown if any of the existing mouse EAE models can
recapitulate specific patterns of demyelination found in
MS. In order to use appropriate models to study specific
pathogenetic mechanisms and to develop more specific
therapies for MS, it is necessary to recognize specific and
distinct demyelinating patterns in EAE.
In this study, we sought to answer the question if autoim-
mune demyelination directed towards an immunodomi-
nant epitope of myelin oligodendrocyte glycoprotein
(MOG35–55), differs between two genetically related sus-
ceptible strains of mice. In addition, if proved that distinct
types of demyelination are genetically determined in
mice, do these patterns share some resemblance with
types of lesions described in MS? In addressing those
questions, we were aided by our previously described
model of MOG35–55 induced EAE in (B6 × SJL) F1 (H-2b/s)
mice, and by comparison to similarly induced EAE in
C57BL/6 (B6) mice [8,9]. These two EAE models were
advantageous for our studies because of the genetic relat-
edness of the parental H-2b and hybrid H-2b/s mice, and
their susceptibility to H-2b restricted MOG35–55. In addi-
tion, we and others reported that H-2b and H-2b/s mice
mount distinct autoimmune responses to MOG35–55,
which include differences in severity, incidence of relapse,
extent and distribution of demyelinating lesions, immun-
opathology and other parameters related to antibody and
T cell autoimmune responses [8,10].
In this study, we examined changes in relative levels of
myelin proteins, which included MOG, myelin associated
glycoprotein (MAG), and myelin basic protein (MBP) in
spinal cord tissue throughout disease, in both strains of
mice. In addition, we measured levels of medium chain of
axonal neurofilament (NF160), and of caspase-cleaved
fragment of poly (ADP-ribose) polymerase, PARPp80, in
spinal cord of EAE mice.
We found preferential, marked depletion of MAG,
decrease of NF160, and sharp elevation of PARPp80 levels
only in relapsing H-2b/s mice. Compared to H-2b, H-2b/s
mice developed more frequent and more severe relapses.
Conversely, relative levels of MOG were reduced during
acute disease in both strains, compared to control values.
Loss of MOG in H-2b/s markedly exceeded that in H-2b
mice. Levels of MBP were moderately decreased only in
relapsing and chronic EAE in H-2b/s mice. Overall, our
data show genetically controlled distinct patterns of
demyelination between H-2b and H-2b/s EAE mice. We
provide evidence of preferential depletion of MAG, sug-
gestive of oligodendrogliopathy, in concert with reduc-
tion of axonal NF160 and rise of PARPp85, in severely
relapsing H-2b/s mice. We propose that MOG-inducedMolecular Neurodegeneration 2008, 3:7 http://www.molecularneurodegeneration.com/content/3/1/7
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relapsing EAE in (B6 × SJL) F1 (H-2b/s) mice may serve as
a useful model in studying mechanisms of autoimmune-
induced preferential loss of MAG and its impact on oli-
godendroglial pathology.
Methods
Mice and induction of EAE
EAE was induced in 8–10-week-old C57BL/6 (B6) (H-2b)
and (B6 × SJL) F1 (H-2b/s) female mice (Jackson Laborato-
ries, Bar Harbor, Maine) by immunization with MOG35–
55 (MEVGWYRSPFSRVVHLYRNGK), 99% pure by HPLC,
(Caltech, Pasadena, CA), as previously described (8). Mice
were daily observed for clinical symptoms of EAE. The
clinical grade was scored as follows: 0.5, partial loss of tail
tonicity; 1, complete loss of tail tonicity; 2, flaccid tail and
abnormal gait; 3, hind leg paralysis; 4, hind leg paralysis
with hind body paresis; 5, hind and foreleg paralysis, 6,
moribund.
Antibodies
The following primary antibodies were used: monoclonal
anti-MAG (1:500 – Chemicon Intl Tamecula CA); and
anti-NF160 (1:320 – Sigma); polyclonal anti-MOG
(1:500), anti- MBP (1:500), and anti-GAPDH (1:1000 –
Santa Cruz Biotechnology, Santa Cruz, CA); anti-
PARPp85 (1:500 – Promega, Maddison, WI). Secondary
antibodies were peroxidase-conjugated and directed
against, mouse, goat or rabbit IgG (R&D Systems, Minne-
apolis, MN).
Sample preparation and western blot
Mice were sacrificed at different stages of relapsing-remit-
ting disease: acute, remission, relapse and chronic.
Approximately 6–7 mice from each strain were analyzed
at each stage of disease, except for H-2b relapsing and H-
2b/s chronic sustained, where 3–4 mice were examined
(Table 1). Anaesthetized mice were perfused through the
heart with 10 ml of ice-cold Phosphate buffered saline
(PBS), and 5 mm thick tissue blocks were dissected from
cervical, thoracic and lumbar spinal cord. Tissue blocks
were either embedded in Tissue Compound (Sigma, St
Louis, Missouri) for tissue section preparation, or alterna-
tively snap frozen, for protein isolation. All tissue samples
were stored at -70°C until use.
Protein was isolated from fresh frozen spinal cord tissue
using TRIzol reagent (Gibco BRL, Grand Island, NY)
according to the procedure recommended by the manu-
facturer. Equal amounts of protein (approximately 20 μg/
lane) from each sample were loaded per lane for Western
blot analysis. Samples were loaded at non-reducing con-
ditions onto NuPage Novex Tris-Acetate Gels (Invitrogen,
Carrsbad, CA), resolved by electrophoresis. Electro-
phoresed proteins were then transferred from the gel onto
nitrocellulose membrane. Membrane was cut into 3–4
strips, each containing proteins of different molecular
weight. Each membrane strip was probed separately with
the appropriate primary antibody overnight at 4°C,
washed three times with 0.1% Tween 20- Tris-buffered
saline, and then incubated with peroxidase conjugated
secondary antibody. The membrane bound peroxidase
activity was detected using ECL Plus western blotting
detection kits (Amersham, Arlington Heights, IL). Chemi-
luminescent images were captured and analyzed by a
Kodak Digital Science Image Station 440CF. All blots were
analyzed within the linear range of exposure. In each sam-
ple levels of MAG, MOG, MBP, NF160 and PARPp85 were
normalized by corresponding levels of GAPDH.
Percoll gradient separation of glia and inflammatory cells
In three separate experiments, which included a total of
10 mice, we used discontinuous Percoll gradients to sepa-
rate infiltrating lymphocytes from resident spinal cord
cells. In each experiment, spinal cord tissue was pooled
from 3–4 mice with relapsing EAE. Anaesthetized mice
were perfused through the heart with 20 ml of ice-cold
phosphate buffered saline (PBS) (Sigma, St Louis, Mis-
souri), and spinal cord was dissected. Tissue was teased
through a wire mesh, and the cell suspension was treated
with DNAse (10 μg/ml) for 10 min at 37°C. DNAse
treated tissue was then overlaid on a discontinuous Per-
coll gradient (Sigma, Saint Louis, Missouri), and centri-
fuged at 3000 rpm for 20 minutes. Infiltrating
lymphocytes were collected in the interface between 25%
and 55% Percoll, while remaining the resident cells,
including glia and neurons, separated on the top of the
Percoll gradient.
Table 1: Disease Incidence and Mean Clinical Severity Score in H-2b/s and H-2b Mice
Disease Incidence and Mean Clinical Severity Score
Acute Relapse Chronic Sustained
Strain Severity Incidence Severity Incidence Severity Incidence
H-2b/s 3.8 ± 0.5 18/18 2.9 ± 0.05 9/12 2.2 ± 0.05 3/12
H-2b 1.7 ± 0.3 18/18 1.0 ± 0.1 3/12 NA 0/12Molecular Neurodegeneration 2008, 3:7 http://www.molecularneurodegeneration.com/content/3/1/7
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Two-color immunostaining and confocal microscopy
Frozen sections (8 – 10 μM) were used to analyze pheno-
types of infiltrating cells by immunofluorescence, follow-
ing a routine procedure [8]. Briefly, sections were air-
dried, acetone-fixed, and treated with 10% normal don-
key serum for 10 minutes, followed by overnight incuba-
tion with relevant primary antibodies (1: 100), in a moist
chamber at +4°C. The slides were then washed and incu-
bated with secondary fluorochrome labeled antibodies
(1:200), (Santa Cruz Biotechology, CA) for 30 minutes.
Nuclear staining with 30 nM 4',6-diamidino-2-phenylin-
dole, dihydrochlpride (DAPI) (Molecular Probes). After
washing, the slides were mounted in Gelmount
(Biomeda, Foster City, CA) and analyzed by light and flu-
orescent microscopy. Images were captured on a Nikon
Eclipse 600 epifluorescent microscope with a Princeton
Instruments Micromax 5 MHz cooled CCD camera.
Hematoxylin-eosin (H&E) staining
Mononuclear cell infiltration was visualized by H& E
staining of a 10 μM thick frozen sections [8]. Briefly, H&
E staining sections were air-dried, fixed in 10% formalde-
hyde, dehydrated, stained for 1 minute with hematoxylin,
then for 2 minutes with eosin (Sigma, St Louis, Missouri),
then dehydrated, and mounted in Permount (Fisher Sci-
entific, Pittsburgh, PA). Luxol fast blue was dropped on
the air-dried section, heated at 60°C for two minutes,
washed, dehydrated, and mounted in Permount.
Statistical analysis
The significance of differences between the groups was
calculated by the Student's t-test or paired-test as appro-
priate. The level of statistical significance was set at ninety-
five percent.
Results
Most profound depletion of MAG levels was exclusive for 
H-2b/s relapsing mice
In spinal cord tissue of EAE H-2b/s and H-2b mice, we
assessed specific changes of relative levels of myelin-asso-
ciated glycoprotein (MAG) by western analysis (Fig. 1).
During acute, relapsing and chronic-sustained disease, rel-
ative levels of MAG were measured and compared to con-
trol values. Control levels of MAG, arbitrarily taken as
100, were indistinguishable between the two strains of
mice. During acute disease, relative levels of MAG were
markedly reduced in H-2b/s compared to control (61 ± 5.9
vs. 100; p < 0.05) and to H-2b mice (61 ± 5.9 vs. 79; p <
0.05). H-2b/s mice reduced their content of MAG approxi-
mately 40% compared to control and about 20% com-
pared to H-2b  mice with acute disease. During EAE
relapse, differences in content of MAG became more pro-
nounced between the two strains of mice. In relapsing H-
2b/s mice, levels of MAG dropped more than two fold
compared to control values (40 ± 3.7 vs. 100; p < 0.05),
while content of MAG in relapsing H-2b mice did not
change significantly (92 ± 8.8 vs. 100). Loss of MAG in H-
2b/s mice with chronic-sustained disease, resembled that
in acute, (66 ± 6.3 vs. 100; p < 0.05). Overall, while both
strains significantly depleted their levels of MAG during
acute disease, loss of MAG in H-2b/s mice was approxi-
mately 20% higher then in H-2b mice. Dissimilar to the
shared trend in reducing MAG levels by both strains of
mice during acute disease, sharp profound drop of MAG
was found only in H-2b/s  strain of mice during EAE
relapse. H-2b/s mice readily exhibited approximately three
times more frequent, and more severe relapsing disease
compared to H-2b mice (2.9 ± 0.05 vs. 1.0 ± 0.1 – Table 1).
MOG levels were markedly lower in H-2b/s compared to H-
2b mice with acute disease, while MOG is being relatively 
spared during relapse
Similarly to regulation of MAG, in acute disease, both
strains of mice exhibited depletion of MOG compared to
control values, H-2b (67 ± 6.5 vs. 100; p < 0.05) and H-2b/
s mice (20 ± 1.8 vs. 100) (Fig. 2). During acute EAE, H-2b/
s mice, which compared to H-2b readily developed more
severe clinical disease (3.8 ± 0.5 vs. 1.7 ± 0.3 – Table 1),
reduction of MOG levels was over three fold more pro-
nounced than in H-2b. Dissimilar to sharp differences
between the two strains of mice in MOG loss during acute
EAE, in relapsing disease, loss of MOG was comparable
between strains. In relapsing mice, significant depletion of
MOG over control levels was in H-2b mice (79 ± 7.4 vs.
100; p < 0.05) and in H-2b mice (72 ± 6.9 vs. 100; p <
0.05). Compared to reduction of MOG in acute disease,
corresponding levels in relapsing H-2b mice did not signif-
icantly change (67 ± 6.5 vs. 79 ± 7.4). On the contrary,
compared to acute levels of MOG in H-2b/s mice, MOG
was markedly preserved during EAE relapse (20 ± 1.8 vs.
72 ± 6.9; p < 0.05). Interestingly, more profound mono-
nuclear cell infiltration was readily observed throughout
the spinal cord of relapsing (B6 × SJL) F1 (H-2b/s), com-
pared to relapsing B6 (H-2b) mice (Fig. 3). Concordant
with relative preservation of MOG during relapsing dis-
ease, in H-2b/s mice with chronic sustained disease this
content did not appear to differ from control values (103
± 10.2 vs. 100).
Modest reduction of relative levels of MBP was found only 
in H-2b/s mice with relapsing and chronic disease
Similarly to constitutive levels of MAG and MOG, control
levels of MBP did not differ significantly between the
strains. In H-2b mice with acute and chronic disease, MBP
levels remained close to control values (98 ± 1.0 and 96 ±
0.9 vs. 100 respectively) (Fig. 4). Similarly to situation in
H-2b mice with acute disease, H-2b/s mice did not exhibit
notable changes in their relative levels of MBP during
acute EAE (99 ± 9.7 vs. 100). As opposed to relative pres-
ervation of MBP during acute disease, in H-2b/s mice withMolecular Neurodegeneration 2008, 3:7 http://www.molecularneurodegeneration.com/content/3/1/7
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relapsing and chronic disease modest reduction of MBP
was found (81 ± 7.7 and 76 ± 7.7 vs. 100; p < 0.05).
Interestingly, levels of all three examined myelin proteins,
MAG, MOG and MBP displayed distinct regulatory pat-
terns in regard to course of disease and to strain of mice
(Fig. 5). In acute disease, both MOG and MAG levels were
depleted in both strains of mice. However, specific loss of
MOG exceeded that of MAG and loss of both proteins in
H-2b/s was markedly higher then in H-2b strain in acute
EAE. Conversely, during relapse, levels of MAG had
dropped markedly only in H-2b/s mice, while remaining
close to control values in relapsing H-2b mice. Levels of
MOG raised compared to acute disease and were compa-
rable between two strains during relapsing EAE. Modest
reduction of MBP levels was found only in H-2b/s mice
with relapsing and even more pronounced during chronic
disease.
Reduction of axonal neurofilament medium chain (NF160) 
correlates with depletion of relative levels of MAG in 
relapsing H-2b/s mice
Profound loss of MAG during acute and especially during
relapsing EAE in H-2b/s mice (Fig. 1) is suggestive of
autoimmune mediated dysfunction and/or even apopto-
sis of oligodendrocytes. Proper function of oligodendro-
cytes is essential for maintenance of axonal homeostasis.
To further investigate if axonal dysfunction and/or apop-
tosis accompany this profound specific depletion of MAG,
we measured levels of neurofilament medium chain
(NF160), and levels of a cleaved fragment of DNA binding
protein PARP, accordingly.
Reduction in axonal neurofilament medium chain
(NF160) was not observed during acute disease in either
H-2b or H-2b/s strain of mice (Fig. 6). Conversely, mice
with relapsing disease exhibited changes in axonal NF160
content. In relapsing H-2b/s  mice, NF160 levels were
approximately two fold reduced compared to control (51
± 4.9 vs. 100; p < 0.05). Reduction in levels of NF160 in
H-2b mice was less prominent compared to H-2b/s mice
but still significant compared to control (80 ± 7.7; p <
0.05). In H-2b/s mice with chronic sustained disease, rela-
Distinct patterns of MOG reduction between H-2b/s and H-2b  mice throughout disease Figure 2
Distinct patterns of MOG reduction between H-2b/s 
and H-2b mice throughout disease. Distinct patterns of 
MOG-specific demyelination were observed between H-2b 
and H-2b/s mice throughout EAE. Relative levels of MOG 
were measured similarly as levels of MAG (Fig.1). As 
opposed to regulation of MAG, most profound depletion of 
MOG was observed in H-2b/s mice during acute EAE. Lesser 
then in H-2b/s, loss of MOG was noted in acute H-2b mice 
during acute disease. Loss of MOG, lesser then in acute but 
significant compared to control values, was equally found in 
H-2b and H-2b/s mice with relapsing disease. In H-2b/s mice 
with chronic-sustained disease levels of MOG were compa-
rable to control values. Stripped and reprobed membrane 
was shown. Corresponding levels of GAPDH are shown in 
Fig. 6.
Profound depletion of MAG levels occurs in relapsing H-2b/s  mice Figure 1
Profound depletion of MAG levels occurs in relapsing 
H-2b/s mice. Dissimilar regulation of relative levels of MAG 
was observed between H-2b and H-2b/s mice throughout EAE. 
Levels of MAG in spinal cord of EAE mice were measured by 
western blot. Approximately 20 μg of total protein was 
loaded per lane. Total of 3–4 mice from H-2b/s and H-2b 
strains with acute and relapsing stages of the disease were 
analyzed. Only H-2b/s mice (3 mice) with chronic-sustained 
disease were examined. Representative blot of 3–4 similar 
experiments shows: acute – H-2b/s (13 dpi, grade 4.5), H-2b 
(16 dpi, grade 4); relapse – H-2b/s (21 dpi, grade 3.5, 1st 
relapse), H-2b (27 dpi, grade 2, 1st relapse); and chronic-sus-
tained – H-2b/s (72 dpi, grade 2.5). Relative levels of MAG 
were calculated as ration to corresponding levels of GAPDH 
(see Fig. 4). Compared to levels in control and in H-2b mice, 
H-2b/s mice markedly reduced their relative levels of MAG 
during acute and chronic. Most profound depletion of MAG 
was found in relapsing H-2b/s mice. Corresponding levels of 
GAPDH are shown in Fig. 6. Membrane was stripped and re-
probed with MOG, MBP, NF160 and PARPp85 antibodies 
(Fig. 2, 4, 6 and 7A).Molecular Neurodegeneration 2008, 3:7 http://www.molecularneurodegeneration.com/content/3/1/7
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tive levels of NF160 were slightly higher than in relapsing
stage of disease, but still markedly lower compared to con-
trol (64 ± 6.1 vs. 100; p < 0.05).
Sharp elevation of PARP-p85 levels was found in relapsing 
H-2b/s mice
Caspase-cleaved fragment of poly (ADP-ribose) polymer-
ase (PARPp85) was not observed in control spinal cord
tissue of either strain of mice (not shown). In acute dis-
ease, small amounts of PARPp85 (18 ± 1.5 in H-2b, and 24
± 2.2 in H-2b/s) were measured (Fig. 7A). Compared to
acute disease, sharp elevation of relative levels of
PARPp85 was found in H-2b/s strain during EAE relapse.
This highest level of PARPp85 was arbitrarily taken as 100.
In relapsing H-2b mice, levels of PARPp85 were almost
two fold less elevated then in relapsing H-2b/s mice (62 ±
6.3 vs. 100: p < 0.05). The sudden rise in PARPp85 in CNS
of relapsing mice indicated apoptosis of either activated
inflammatory cells and/or resident glia. To investigate the
contribution of non-inflammatory cell phenotypes to the
abrupt elevation of cleaved PARP in relapsing mice, we
measured PARPp85 in glial/neuronal fraction following
Percoll separation (Fig. 7B). Similar to whole spinal cord
tissue, in the glial/neuronal fraction, elevation of
PARPp85 was similar when H-2b and H-2b/s strains were
compared (50 ± 4.8 vs. 100; p < 0.05). However, when
glial and whole tissue PARPp85 levels were compared for
each strain of mice, it became apparent that the glial/neu-
ronal fraction represented approximately 60% in H-2b
and 75% in H-2b/s mice.
As anticipated, appreciable levels of PARPp85 were meas-
ured in the fraction devoid of inflammatory mononuclear
cells, thus suggesting that cleavage of PARP occurs in glia
and/or neurons during EAE relapse. This observation was
further confirmed by immunostaining. By two-color
immunostaining it became apparent that some of
PARPp85 immunoreactivity co-localized with some MBP
containing cells in spinal cord of relapsing H-2b/s mice
(Fig. 8). While some of the PARPp85 immunostaining
was observed within the cytoplasm, more importantly it
was also found in some nuclei (Fig. 8). Consistent with
finding of PARp85 in percoll gradient-separated glial/neu-
ronal fraction, PARPp85 immunostaining did not notably
co-localize to infiltrating submeningeal mononuclear
cells (Fig. 8, merge – upper right).
Taken together, profound reduction of NF160, accompa-
nied with sudden elevation of PARPp80 and marked
reduction of MAG was found in relapsing H-2b/s mice.
(Fig. 9)
Discussion
Oligodendroglial damage and/or dysfunction are critical
features in the pathogenesis of MS [3]. Damage to oli-
godendrocytes precludes maintenance of homeostatic
myelin-axonal signaling and their proper communica-
tion. Those changes are typically thought to be irreversible
and to have profound impacts on function of myelinated
axons [11]. Distal oligodendrogliopathy, whose pathoge-
netic mechanisms are still unclear, is readily found in the
subtype III of acute MS demyelinating lesion [2,12]. It is
unknown if there is an appropriate EAE correlate for this
specific subtype of MS immunopathology. Finding an
EAE model which recapitulates at least some key features
observed in the subtype III MS lesion, will greatly propel
studies on the mechanisms leading to oligodendroglial
H&E staining reveals an extensive mononuclear cell infiltra- tion in spinal cord of (B6 × SJL) F1 (H-2b/s) relapsing mice  (top panel) Figure 3
H&E staining reveals an extensive mononuclear cell infiltra-
tion in spinal cord of (B6 × SJL) F1 (H-2b/s) relapsing mice 
(top panel). In these mice inflammatory cells are evident 
throughout the spinal cord parenchyma. Lesser degree of 
inflammation was observed in relapsing B6 (H-2b) mice 
(lower panel). Representative image shows lumbar spinal 
cord from relapsing H-2b/s mouse, with clinical severity score 
of 3, and relapsing H-2b mouse with severity score of 2. (H&E 
× 10).Molecular Neurodegeneration 2008, 3:7 http://www.molecularneurodegeneration.com/content/3/1/7
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damage and enable development of new therapies. While
such model is desirable one should always remain critical
about strain specific differences in regulation of autoim-
mune responses between rodents and humans. Neverthe-
less, genetic regulation of immune responses makes some
strains of mice more comparable to some aspects of
human disease than others. We reported distinct appear-
ance and distribution of demyelinating lesions in spinal
cord of H-2b and H-2b/s EAE mice, by means of histochem-
istry. While in H-2b  mice demyelinating lesions were
found predominantly in submeningeal areas, in H-2b/s
mice, small, scattered, perivenular lesions were observed
throughout white matter parenchyma (Fig. 3) and [8].
Those differences were suggestive of distinctive genetic
regulation of autoimmune mediated demyelination
between H-2b and H-2b/s EAE mice. Molecular mecha-
nisms leading to higher susceptibility of hybrid compared
to parental strain of mice remain elusive. Based on this
initial observation, we sought to answer if those appar-
ently discrete autoimmune responses, initiated by immu-
nization with MOG35–55, cause distinctive damage to
myelin and/or the myelin forming cells, oligodendro-
cytes, which then underlie readily relapsing and more
severe clinical disease in H-2b/s mice. Therefore, in this
study we measured and compared changes in relative lev-
els of the myelin proteins MOG, MAG and MBP, through-
out disease, in these two genetically related strains of
mice. We anticipated that autoimmune mechanisms gov-
erned by T-cells and antibodies initiated towards MOG35–
55, will be primarily responsible for an initial depletion of
MOG levels, in both strains of mice. Our data confirmed
marked depletion of MOG levels during an acute disease
in both H-2b and H-2b/s mice. However, relative levels of
MOG are more profoundly depleted in H-2b/s, which
developed significantly more severe acute disease com-
pared to H-2b  mice. More pronounced loss of MOG,
found in H-2b/s mice with acute and relapsing disease, was
in concert with elevated memory T cell and antibody
responses to MOG35–55 in these mice [8,10]. Interestingly,
depletion of MOG was less apparent in relapsing mice
compared to acute, in both strains. Recovered levels of
MOG in relapsing mice may result from attempted remy-
elination, which has been reported to take place in MOG
Correlation between levels of MAG, MOG and MBP  inH-2b/s and H-2b mice has revealed dissimilar regulation of  MAG and MOG in relapsing H-2b/s mice Figure 5
Correlation between levels of MAG, MOG and MBP 
inH-2b/s and H-2b mice has revealed dissimilar regulation of 
MAG and MOG in relapsing H-2b/s mice.
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Discrete changes in MBP levels in CNS of H-2b/s and H-2b  mice throughout EAE Figure 4
Discrete changes in MBP levels in CNS of H-2b/s and 
H-2b mice throughout EAE. Discrete changes in MBP lev-
els were observed in spinal cord of H-2b and H-2b/s mice 
throughout EAE. Relative levels of MBP were measured simi-
larly as levels of MAG (Fig. 1). Compared to control values, 
modest reduction of MBP levels was measured only in H-2b/s 
mice during relapsing and chronic-sustained EAE. This anti-
body revealed presence of four distinct closely related 21–26 
KD isoforms of MBP in control and EAE spinal cord, similarly 
as reported by the manufacturer of this antibody. These iso-
forms may be the result of posttranslational modification of 
MBP. Stripped and re-probed membrane was shown. Corre-
sponding levels of GAPDH are shown in Fig. 6.Molecular Neurodegeneration 2008, 3:7 http://www.molecularneurodegeneration.com/content/3/1/7
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induced EAE in H-2b mice by our laboratory and others
[13,14].
Compared to MOG, which was an apparent target of
autoimmune-induced responses, and which is located in
the outer myelin wraps, MAG was an unlikely candidate
for autoimmune-induced damage. This myelin protein is
located in the most inner loop of the myelin sheet and it
serves as a specific oligodendroglial functional marker
[11]. Specific periaxonal localization of MAG implicates a
role of this glycoprotein in bi-directional oligo-axonal
communication. It is proposed that MAG serves as a lig-
and for a receptor complex involving the Nogo receptor
and/or gangliosides containing 2,3-linked sialic acid. It
provides signal necessary for the maintenance of myeli-
nated axons and acts as one of white matter inhibitors of
neurite outgrowth. Conversely, MAG serves as a receptor
for axonal signals that regulate homeostasis and survival
of oligodendrocytes [15]. CNS pathologies, including
autoimmune myelin specific mechanisms, inflammation,
reduced vascular perfusion, can induce oligodendroglial
dysfunction and/or apoptosis mediated death of oli-
godendrocytes. In those conditions, reduction in specific
levels of MAG appeared either as an early indicator of
compromised oligodendroglial function, or as a sign of
oligodendrogliopathy [16]. Demyelination leads to
axonal dysmorphia and degeneration in MS and other
demyelinating diseases. A unifying hypothesis that links
neuronal stress associated with demyelination-induced
axonal dysfunction to immune recognition and immun-
opathology has been recently proposed [17].
Our findings of preferential loss of MAG over MBP corre-
late well with observation based on immunocytochemical
distribution of MAG and MBP in MS lesions [18]. The
authors reported that the most striking finding in MS
lesions was the extent of MAG depletion into white matter
that appeared normal by criteria of MBP immunostaining.
They also described that loss of MAG had extended far
beyond the margin of acute demyelination, where MBP
staining of degenerated sheaths was often increased. They
suggested that periaxonal MAG is altered before the mye-
lin breakdown begins in MS. We hypothesize that in H-2b/
s EAE mice autoimmune induced stripping of MOG from
the myelin sheath, and subsequent autoimmune-induced
inflammation cause changes in axonal to oligodendrocyte
signaling through MAG, with subsequent reduction of
MAG levels. Accordingly, in H-2b/smice we found mark-
edly reduced levels of MAG in acute and even more pro-
nounced in relapsing disease. In addition inflammatory
mediators induce a cascade activation of resident glial
cells, microglia, astrocytes, dendritic cells, which extends
beyond margins of demyelinating lesion. It is possible
that in normal appearing white matter MAG becomes
depleted as a result of neighboring cell activation and sub-
sequent expression and local release of inflammatory
mediators. Such mechanism may be responsible for even
more profound loss of MAG found in H-2b/s mice with
relapsing and chronic sustained disease.
It is also possible that some other genetically determined
mechanism, which may or may not be directly related to
autoimmune response to MOG in H-2b/smice underlies
this profound loss of MAG. Interestingly, in patients with
relapsing and remitting MS, who died shortly or during
the onset of relapse, oligodendroglial apoptosis and
microglial activation without apparent demyelination or
extensive adjacent inflammation were observed [19].
While both studies in MS [[18] and [19]] used classical
histopathology and immunopathology approaches, our
study, similarly to some other studies in EAE [20] utilizes
biochemical measurement of molecular markers of demy-
elination. Our ongoing histopathology studies of these
and other markers depicting demyelination, apoptosis
and oligo-axonal communication, will enable better com-
parison of biochemical changes found in relapsing H-2b/s
mice with histopathology changes reported in MS.
We anticipated that additional loss of other, more accessi-
ble myelin proteins, such as MBP, may occur during
relapsing disease as a result of endogenous self priming
and subsequent epitope spreading, at least in H-2b/s mice.
It is proposed that posttranslational modifications of
MBP, such as citrulination or deamination, change bind-
Distinctive changes of NF160 levels in CNS throughout dis- ease between H-2b/s and H-2b mice Figure 6
Distinctive changes of NF160 levels in CNS through-
out disease between H-2b/s and H-2b mice. Relative lev-
els of medium chain of neurofilament (NF160) were 
significantly depleted in mice with relapsing and chronic dis-
ease. Relative levels of NF160 were measured similarly as 
levels of MAG (Fig.1). Most profound drop in NF160 levels 
was observed in relapsing H-2b/s mice.Molecular Neurodegeneration 2008, 3:7 http://www.molecularneurodegeneration.com/content/3/1/7
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ing affinity of this myelin protein for negatively charged
lipids on the cytosolic portion of oligodendrocyte mem-
brane thus making it relatively exposed and accessible to
autoimmune attack [21]. Surprisingly, we did not find
appreciable reductions in levels of MBP, in either low-
relapsing H-2b or severely relapsing H-2b/s strains of mice.
It is possible that relative lack of epitope spreading to MBP
specific epitopes was due to non-permissive or low-per-
missive H-2 haplotypes in these two strains of mice.
Because of the H-2 restriction of autoimmune responses
to myelin proteins, immunodominant epitopes of MBP
were not likely to induce disease in H-2b mice, while in H-
2b/s mice those responses are low following immunization
with MBP [[22,23], and Skundric DS, Dai R Zhou W.
Immune responses to H-2s  restricted encephalitogenic
epitopes in H-2b/s mice, unpublished]. Taken together,
dissimilar regulation of major myelin proteins MOG,
MAG and MBP, suggest that genetically conducive envi-
ronment in H-2b/s mice favors an excessive loss of MAG
during relapsing disease. Data suggest that potential oli-
godendroglial dysfunction and/or damage may underlie
severe relapsing disease in these mice. Interestingly, dis-
tinct regulation of another myelin protein DM20, a splice
variant of proteolipid protein (PLP), has been observed
between two distinct patterns of recovery and types of
remyelination in PLP-induced EAE in mice [24].
Homeostatic properties of oligodendroglia span beyond
production, maintenance and escheatment of axons of
the central nervous system (CNS). Proper oligodendro-
glial-axonal communication is essential for axonal func-
tion. Axonal dysfunction and even more profoundly,
axonal loss, which is responsible for motor deficits in MS
and EAE, are inherent. Neurofilaments (NF), the major
type of intermediate filaments in adult neurons, comprise
three subunits: light (NFL; 68 kDa), medium (NFM; 160
kDa) and heavy (NFH; 200 kDa). Quantification of neu-
rofilaments is routinely used in MS and EAE as a measure
Two-color immunostaining reveals co-localization of  PARPp85 and some MBP immunoreactivity (merge and  merge detail) Figure 8
Two-color immunostaining reveals co-localization of 
PARPp85 and some MBP immunoreactivity (merge and 
merge detail). Some PARPp85 is found in cell nuclei, whose 
morphology is suggestive of apoptosis (asterix). Other nuclei 
with PARPp85 immunoreactivity appear round and small 
(arrowhead). The remaining PARPp85 immunostaining 
appears extranuclear and relates to cells expressing MBP 
immunoreactivity (arrows). Note relative absence of 
PARPp85 in submeningeal mononuclear cells (merge – upper 
right). (Two-color immunofluorescence × 20 and 40).
Differences in levels of PARPp85 between H-2b/s and H-2b  EAE mice Figure 7
Differences in levels of PARPp85 between H-2b/s and 
H-2b EAE mice. Relative levels of PARPp85 were measured 
in spinal cord (A) and in Percol gradient separated fraction of 
spinal cord, which was devoid of infiltrating inflammatory 
cells (B). Relative levels of PARPp85 in spinal cord were 
determined similarly as levels of MAG (Fig. 1). The highest 
level of PARPp85 was found in relapsing H-2b/s mice, and this 
value was arbitrarily taken as 100. Compared to this highest 
level, significantly lower relative levels of PARPp85 were 
observed during acute and chronic disease. Stripped and re-
probed membrane was shown for levels of PARPp85 in spinal 
cord. Corresponding levels of GAPDH are shown in Fig. 6.Molecular Neurodegeneration 2008, 3:7 http://www.molecularneurodegeneration.com/content/3/1/7
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of neurodegeneration [20,25]. We already showed that
increased phosphorylation of medium and heavy neuro-
filaments [NF (M+H) P] associates with increased inflam-
mation in MS lesions [26]. Recent findings point out an
important role of NF160 in outside-in myelin-axonal sig-
naling essential for axonal homeostasis. Therefore deple-
tion of this neurofilament causes axonal dysfunction, a
more discrete change compared to axonal degeneration or
axonal loss [6,27]. Similarly to our findings reversible
axonal injury but not axonal loss was found to accompany
inflammation in acute EAE. Moreover, in vitro destabili-
zation of axonal microtubules was directly mediated by
co-culture with encephalitogenic T cells. This led to tran-
sient axonal dysfunction [28]. In MS and EAE axonal loss
may partially occur as a result of Wallerian degeneration
(WD) and in that case it does not necessarily links to
demyelination and damage of oligodendrocytes. To get
insight into relationship between demyelination and
axonal loss, we compared MBP and NF160 specific immu-
noreactivity in H-2b/s and H-2b mice. This strategy did not
reveal significant differences between two strains. In both
H-2b/s [see Additional file 1] and H-2b mice [see Addi-
tional file 2], lack of co-localization may be found as well
as areas of co-localized MBP and NF160 immunostaining.
While WD is present in complex pathology of MS and
EAE, it is not believed to be the major cause of disability
in these diseases. WD has been reported in most EAE
models, not only MOG-related [29]. It can be nicely dem-
onstrated in 1 μm toluidine blue stained thin section or by
EM. We showed presence of WD in SJL and C57BL/Ka
mice with EAE induced by immunization with MBP or
adoptive transfer of MBP sensitized and in vitro stimu-
lated MBP specific T cells [30,31]. In our subsequent man-
uscript, we demonstrated presence of WD in (B6 × SJL)F1
mice immunized with MOG, using EM [13]. We similarly,
observed signs of WD in MOG immunized B6 mice
(Skundric, unpublished).
In EAE, an autoimmune-induced infiltration by activated
T cells and monocytes triggers cascade reaction of glial
activation [32]. Conversely, in CNS microenvironment,
activation-induced apoptosis of inflammatory cells and
functional and morphological changes of glia, including
apoptosis, control the overall tissue damage and outcome
of inflammation [[33-35], and [36]]. Poly (ADP-Ribose)
polymerase (PARP) is a nuclear enzyme with an impor-
tant role for DNA repair. Through its interactions with NF-
κB, PARP is involved in regulation of cellular inflamma-
tory responses [37,38]. In an EAE model in marmosets,
activation of PARP-1 was observed in endothelial cells,
neurons and glia, including oligodendrocytes, within
demyelinating plaques [39]. Although PARP is not indis-
pensable for progression of apoptosis the cleavage of
PARP contributes to the irreversibility of apoptosis.
Overall, our data show that profound reduction of MAG
levels correspond to depletion of NF160, and sharp eleva-
tion of PARPp85 exclusively in relapsing H-2b/s mice.
These data correlates with our previously reported find-
ings of markedly increased infiltration by CD4+ T cell, lev-
els of pro-inflammatory cytokine IL-16, activated caspase-
3, in relapsing H-2b/s compared to H-2b mice [40]. Con-
current with our previous data, we readily observed
mononuclear infiltrates around small blood vessels
throughout white matter parenchyma in relapsing H-2b/s
mice, as opposed to H-2b mice, where mononuclear cells
preferentially infiltrated to submeningeal spaces (Fig. 3),
[8]. This characteristic perivascular location of inflamma-
tory cells in relapsing H-2b/s mice may be responsible for
eventual vascular changes and/or hypoperfusion, which
may result in the loss of MAG [16]. Studies focusing on
specific changes in vascular perfusion in relapsing H-2b/s
mice are under way in our laboratory.
We propose that MOG-induced EAE in H-2b/s mice may
prove as a useful model in studying underlying autoim-
mune mechanisms which regulate preferential loss of
Correlation between MAG, NF160 and PARPp85 lev- els in H-2b/s and H-2b mice has revealed similar regulation of  MAG and NF160 in relapsing H-2b/s mice Figure 9
Correlation between MAG, NF160 and PARPp85 lev-
els in H-2b/s and H-2b mice has revealed similar regulation of 
MAG and NF160 in relapsing H-2b/s mice. Dissimilar to pro-
found drop of MAG and NF160, sharp elevation of PARPp85 
was observed in these mice.
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MAG and potentially related oligodendroglial dysfunc-
tion/apoptosis.
Conclusion
Taken together, our results show genetically controlled
distinct patterns of MOG and MAG specific depletion, in
MOG-peptide induced EAE in H-2b and H-2b/s mice. The
data also suggest distinctive immune regulation of relaps-
ing compared to acute disease. A specific profound deple-
tion of MAG, concomitant with marked depletion of
axonal NF160, and sharp elevation of PARPp85 levels,
occurred exclusively in relapsing H-2b/s mice. Our findings
indicate concurrence of preferential depletion of MAG,
axonal dysfunction and signs of irreversible apoptosis
with severe relapsing disease in H-2b/s  mice. Autoim-
mune-induced preferential loss of MAG over other myelin
proteins may be suggestive of oligodendroglial dysfunc-
tion/damage in relapsing H-2b/s mice.
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